← Leaderboards
Katherine L Nathanson
University Of Pennsylvania
$24,205,332
Attributed
$45,798,018
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,798,018 · 16
By mechanism
R01$20,838,940 · 7
U01$16,690,389 · 2
T32$3,700,596 · 1
P50$1,572,609 · 1
P01$1,536,692 · 1
R21$678,050 · 2
Top collaborators
- Fergus Joseph Couch10 shared
- Peter A Kanetsky9 shared
- Marylyn D Ritchie9 shared
- Jason H. Moore6 shared
- Keith T Flaherty5 shared
- William M Lee5 shared
- David E. Goldgar4 shared
- Kenneth Offit4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Stephen G Emerson$28,932,839
- Monica E Calkins$749,909
- Keith T Flaherty$13,209,948
- William M Lee$5,600,205
- Bruce I Turetsky$8,247,305
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBaseGeneticGenesPredispositionVariantInheritedIncidenceMutationAffectAccountingTumorPathway InteractionsProgramsCancer RiskTesticular Germ Cell TumorAreaMemberGenotypeResourcesGenomicsResearch PersonnelResponseClinical Trials
Grant awards (79)
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$812,074
R01 · FY2025 · HG · contact PI
Postdoctoral Training Program in Genomic Medicine$475,419
T32 · FY2025 · HG · contact PI
Post genome wide association studies in testicular germ cell tumors$1,087,592
U01 · FY2024 · CA · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$790,117
R01 · FY2024 · HG · contact PI
Postdoctoral Training Program in Genomic Medicine$426,083
T32 · FY2024 · HG · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$877,709
R01 · FY2023 · HG · contact PI
Post genome wide association studies in testicular germ cell tumors$766,653
U01 · FY2023 · CA · contact PI
Postdoctoral Training Program in Genomic Medicine$249,889
T32 · FY2023 · HG · contact PI
Post genome wide association studies in testicular germ cell tumors$1,426,684
U01 · FY2022 · CA · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$924,042
R01 · FY2022 · HG · contact PI
Postdoctoral Training Program in Genomic Medicine$552,157
T32 · FY2022 · HG · contact PI
Core C: Immune bioinformatics and biostatistics$288,059
P01 · FY2022 · CA · contact PI
Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer$143,595
U01 · FY2022 · CA · contact PI
Post genome wide association studies in testicular germ cell tumors$1,462,174
U01 · FY2021 · CA · contact PI
Postdoctoral Training Program in Genomic Medicine$534,178
T32 · FY2021 · HG · contact PI
Core C: Immune bioinformatics and biostatistics$293,404
P01 · FY2021 · CA · contact PI
Post genome wide association studies in testicular germ cell tumors$1,475,426
U01 · FY2020 · CA · contact PI
Postdoctoral Training Program in Genomic Medicine$515,347
T32 · FY2020 · HG · contact PI
Biomedical Computing and Informatics Strategies for Precision Medicine$332,242
R01 · FY2020 · LM
Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer$4,815,109
U01 · FY2019 · CA · contact PI
Postdoctoral Training Program in Genomic Medicine$431,817
T32 · FY2019 · HG · contact PI
Biomedical Computing and Informatics Strategies for Precision Medicine$332,372
R01 · FY2019 · LM
Core C: Immune bioinformatics and biostatistics$296,077
P01 · FY2019 · CA · contact PI
Cancer Control Research Program$7,213
P30 · FY2019 · CA · contact PI
Cancer Control Research Program$5,768
P30 · FY2019 · CA · contact PI
Cancer Control Research Program$3,627
P30 · FY2019 · CA · contact PI
Cancer Control Research Program$1,106
P30 · FY2019 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,055,961
R01 · FY2018 · CA
Identifying and validating novel susceptibility genes for breast cancer$684,391
R01 · FY2018 · CA
Postdoctoral Training Program in Genomic Medicine$336,472
T32 · FY2018 · HG · contact PI
Core C: Immune bioinformatics and biostatistics$320,694
P01 · FY2018 · CA · contact PI
Association of Inherited Variation in Immune Mediated Adverse Events and Respons$320,512
P50 · FY2018 · CA · contact PI
Cancer Control Research Program$9,404
P30 · FY2018 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,263,145
R01 · FY2017 · CA
Identifying and validating novel susceptibility genes for breast cancer$680,501
R01 · FY2017 · CA
Core C: Immune bioinformatics and biostatistics$338,458
P01 · FY2017 · CA · contact PI
Association of Inherited Variation in Immune Mediated Adverse Events and Respons$316,566
P50 · FY2017 · CA · contact PI
Postdoctoral Training Program in Genomic Medicine$179,234
T32 · FY2017 · HG · contact PI
Cancer Control Research Program$73,100
P30 · FY2017 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,299,901
R01 · FY2016 · CA
Identifying and validating novel susceptibility genes for breast cancer$675,236
R01 · FY2016 · CA
Association of Inherited Variation in Immune Mediated Adverse Events and Respons$335,891
P50 · FY2016 · CA · contact PI
Cancer Control Research Program$72,888
P30 · FY2016 · CA · contact PI
Post GWA Studies in Testicular Germ Cell Tumors$1,374,735
U01 · FY2015 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,319,364
R01 · FY2015 · CA
Identifying and validating novel susceptibility genes for breast cancer$676,922
R01 · FY2015 · CA
Association of Inherited Variation in Immune Mediated Adverse Events and Respons$299,473
P50 · FY2015 · CA · contact PI
Investigating the association between the somatic and inherited genetics of pheoc$174,000
R21 · FY2015 · CA · contact PI
Post GWA Studies in Testicular Germ Cell Tumors$1,497,780
U01 · FY2014 · CA · contact PI
Risk and penetrance of mutations from breast cancer testing panels.$1,408,225
R01 · FY2014 · CA
Identifying and validating novel susceptibility genes for breast cancer$704,905
R01 · FY2014 · CA
Association of Inherited Variation in Immune Mediated Adverse Events and Respons$300,167
P50 · FY2014 · CA · contact PI
Investigating the association between the somatic and inherited genetics of pheoc$187,050
R21 · FY2014 · CA · contact PI
Post GWA Studies in Testicular Germ Cell Tumors$1,451,724
U01 · FY2013 · CA · contact PI
Genotype and phenotype predictors in therapy response in renal cell carcinoma$421,339
R01 · FY2013 · CA
Post GWA Studies in Testicular Germ Cell Tumors$1,188,917
U01 · FY2012 · CA · contact PI
Genotype and phenotype predictors in therapy response in renal cell carcinoma$447,222
R01 · FY2012 · CA
Inherited genetic variation and predisposition to testicular germ cell tumor$529,388
R01 · FY2011 · CA · contact PI
Genotype and phenotype predictors in therapy response in renal cell carcinoma$449,030
R01 · FY2011 · CA
Somatic genetic predictors of response to therapy in metastatic melanoma$299,308
R01 · FY2011 · CA · contact PI
Inherited genetic variation and predisposition to testicular germ cell tumor$568,839
R01 · FY2010 · CA · contact PI
Genotype and phenotype predictors in therapy response in renal cell carcinoma$489,269
R01 · FY2010 · CA
Somatic genetic predictors of response to therapy in metastatic melanoma$308,319
R01 · FY2010 · CA · contact PI
Inherited genetic variation and predisposition to testicular germ cell tumor$568,104
R01 · FY2009 · CA · contact PI
Genotype and phenotype predictors in therapy response in renal cell carcinoma$508,622
R01 · FY2009 · CA
Somatic genetic predictors of response to therapy in metastatic melanoma$309,344
R01 · FY2009 · CA · contact PI
Inherited genetic variation and predisposition to testicular germ cell tumor$294,939
R01 · FY2009 · CA · contact PI
Inherited genetic variation and predisposition to testicular germ cell tumor$562,236
R01 · FY2008 · CA · contact PI
Somatic genetic predictors of response to therapy in metastatic melanoma$314,405
R01 · FY2008 · CA · contact PI
Inherited genetic variation and predisposition to testicular germ cell tumor$617,290
R01 · FY2007 · CA · contact PI
Somatic genetic predictors of response to therapy in metastatic melanoma$314,179
R01 · FY2007 · CA · contact PI
Using array CGH to identify prostate cancer genes$158,500
R21 · FY2005 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$62,924
K08 · FY2005 · CA
Using array CGH to identify prostate cancer genes$158,500
R21 · FY2004 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$125,847
K08 · FY2004 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$125,847
K08 · FY2003 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$62,924
K08 · FY2002 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$115,047
K08 · FY2001 · CA
IDENTIFYING MODIFYING GENES IN BRCA1 MUTATION CARRIERS$115,047
K08 · FY2000 · CA